Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Abramson Cancer Center at Penn Medicine
Study ID
NCT07048496
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • BCG delivery at home — OTHER
    The BCG at home project will be a single-arm prospective pilot, to evaluate the feasibility, scalability and effectiveness of home treatment, and utilize the BB-Bot (chatbot) for PRO and adverse event measurement.

Study Details

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Key Dates

Start date
Jul 5, 2025
Status verified
May 2026
Primary completion
Aug 5, 2026
Completion
Sep 5, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Rate of adherence to BCG therapy at 3 months after study initiation [ Time Frame: 3 months after study initiation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Abramson Cancer CenterPhiladelphiaPennsylvania19104
Daniel J Lee, MD, MS
[email protected]
215-662-2891

Find similar trials in Philadelphia, PA

By condition
Bladder cancer
By specialty
OncologyUrology
By research site
Abramson Cancer Center· Philadelphia, PA

Related Studies